Ginkgetin delays the progression of osteoarthritis by inhibiting the NF-κB and MAPK signaling pathways
Abstract Background Osteoarthritis (OA) is considered an advancing chronic degenerative joint disease, leading to severe physical functional impairment of patients. Its development is closely related to increased inflammation and oxidative stress within the joint. Ginkgetin (GK), a natural non-toxic...
Saved in:
Main Authors: | Liang Zhu, Yanchi Bi, Ting Liang, Po Zhang, Xiao Xiao, Tengbo Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | Journal of Orthopaedic Surgery and Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13018-025-05525-5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Investigating the mechanisms of ginkgetin-mediated reversal of cisplatin resistance in cervical cancer through network pharmacology and molecular docking approaches
by: Fei Wang, et al.
Published: (2025-02-01) -
Bergapten alleviates senescence of chondrocytes in osteoarthritis
by: YE Yuanlan, et al.
Published: (2025-02-01) -
Therapeutic potential of SOX family transcription factors in osteoarthritis
by: Yue Huang, et al.
Published: (2025-12-01) -
Brucella osteoarthritis: recent progress and future directions
by: Jinlei Chen, et al.
Published: (2025-02-01) -
Cordycepin Protects against Hepatic Ischemia/Reperfusion Injury via Inhibiting MAPK/NF-κB Pathway
by: Jiameng Ding, et al.
Published: (2022-01-01)